Pathways’ Picks July 29: Multi-Function Devices, China Trial Exemptions, ISO Clinical Standard, and More

article image

In this week’s roundup: FDA finalizes its policy for addressing “multiple function” devices, China proposes dozens of new devices for clinical trial exemptions, the long-awaited ISO 14155 clinical investigation standard is released, and more policy insights.

When a product under review by FDA performs at least one function that is regulated as a medical device and at least one that falls outside of the agency’s oversight jurisdiction, where is the line FDA can’t cross during its assessment? A guidance document issued by the agency July 28 attempts to answer this question in our lead Pathways’ Pick. Also: clinical trial exemptions in China, ISO clinical study standards, and more global medtech policy news.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: